Skip to content
OpenDue March 26, 2026

Illumina MiSeq i100 System or equal

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Who can apply

No Set aside used. NONE

About this opportunity

NOTICE OF INTENT TO SOLE SOURCE Description This notice is issued for informational and market research purposes only and does not constitute a solicitation. The FDA intends to award a sole source Firm-Fixed-Price purchase order for one (1) Whole Genome Sequencing instrument. The Government is considering the Illumina MiSeq i100 System or equal product that meets all salient characteristics identified in the Statement of Work (SOW). Offerors proposing equal products shall demonstrate how the proposed product meets each of the salient characteristics The instrument shall include a minimum one (1) year manufacturer�s warranty covering parts and labor. Response Instructions Interested parties shall submit capability statements demonstrating ability to meet requirements. Offerors proposing an ...

Finding similar opportunities...